Eligibility

Eligible Ages

Over 18 Years

Eligible Sex

All

Accepts Healthy Volunteers

Yes

Criteria

Eligibility Criteria for Patients:

- Adult participants (18+) eligible for one of three participating trials at
Washington University, University of Utah, or University of North Carolina at Chapel
Hill. The eligibility criteria for the main trials are below:

- UNC:

- Basal-like PDAC Treated with Gemcitabine, Erlotinib, and Nab-paclitaxel
(PANGEA) trial inclusion criteria:

- Written informed consent was obtained to participate in the study and
HIPAA authorization for release of personal health information.

- Participant is willing and able to comply with study procedures based
on the judgment of the investigator.

- Age ≥ 18 years at the time of consent.

- Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1.

- Consent to a mandatory pre-study biopsy if archival tissue is not
available or sufficient.

- Participants with a prior or concurrent malignancy whose natural
history or treatment does not have the potential to interfere with
the safety or efficacy assessment of the investigational regimen.

- Washington University:

- Returning Research Results That Indicate Risk of Alzheimer Disease
Dementia to Healthy Participants in Longitudinal Studies (WeSHARE)

- Participants of the Knight Alzheimer Disease Research Center.

- Participants with available results from an Alzheimer Disease blood
biomarker test.

- Participants who agreed to be contacted for additional research
studies.

- University of Utah:

- Huntsman Cancer Institute Total Cancer Care

- Participants who have been diagnosed with any type of tumor or
cancer.

- Participants with genetic predispositions or family history of cancer
or tumors.

- Participant volunteers willing to share samples and data for
research.

Eligibility Criteria for Research Staff:

- Research staff/coordinators of one of the three participating trials at Washington
University, University of Utah, or University of North Carolina at Chapel Hill.